Skip to main content

Table 1 Characteristics of patients (n.25)

From: A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

Characteristic

n(%)

Age (years)

 

   Median

51

   Range

39–69

   P. S 0–1

20(80%)

   P. S 2

5 (20%)

Histology

 

   Infiltrating ductal ca

19 (76)

   Infiltrating lobular ca

6 (14)

Estrogen status

 

   ER+

14 (56)

   ER -

7 (28)

   Unknown

4 (16)

Dominant sites of metastases

 

   Nodes

10(40)

   Soft tissues

2(8)

   Bone

5(20)

   Liver

8(32)

   Lung

7(28)

Pretreatment with antracyclines

 

   Adjuvant CT

11(44)

   Not adjuvant CT

14(56)